Alamar Biosciences, Inc. (California) (ALMR)

25.34 -2.08 (-7.60%) USD  |  NASDAQ  |  Oct 16, 14:06
More

Alamar Biosciences SG&A Expense (TTM) : 31.22M for June 30, 2026

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2026 31.22M
March 31, 2026 13.79M
Date Value
June 30, 2025 0.00
March 31, 2025 0.00

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Personalis, Inc. 67.03M
10X Genomics, Inc. 297.01M
Adaptive Biotechnologies Corp. 180.38M
Champions Oncology, Inc. 21.81M
Medpace Holdings, Inc. 189.02M